Indium (111In) biciromab

Pharmaceutical compound From Wikipedia, the free encyclopedia

Indium (111In) biciromab (INN, trade name FibriScint, developed by Centocor) was a drug targeting fibrin, a protein involved in the clotting of blood.[1] It was the Fab' fragment of a mouse monoclonal antibody labelled with the radioisotope indium-111 for the diagnosis of thromboembolism,[2] but was withdrawn during clinical trials.[3]

Quick facts Monoclonal antibody, Type ...
Indium (111In) biciromab
Monoclonal antibody
TypeFab' fragment
SourceMouse
TargetFibrin II, beta chain
Clinical data
Trade namesFibriScint
Pregnancy
category
  • N/A
ATC code
  • none
Legal status
Legal status
  • Withdrawn
Identifiers
CAS Number
ChemSpider
  • none
KEGG
 ☒NcheckY (what is this?)  (verify)
Close

References

Related Articles

Wikiwand AI